期刊文献+

ARID1A及PIK3CA在膀胱尿路上皮癌中的表达及临床病理意义 被引量:1

Expression and significance of ARID1A and PIK3CA in bladder urothelial carcinoma
原文传递
导出
摘要 目的:探讨膀胱尿路上皮癌(BUC)组织中ARID1A及PIK3CA的表达及意义。方法:采用免疫组化EnVision法检测107例膀胱尿路上皮癌(BUC组)及28例癌旁组织(癌旁组)中ARID1A、PIK3CA及Ki-67的表达水平,并将BUC组按照临床病理特征进行分组,统计分析ARID1A、PIK3CA在各组间表达的差异及相关性。结果:ARID1A在BUC组中有42.06%呈缺失表达,而在癌旁组中仅7.14%呈缺失表达,二者差异有统计学意义(P<0.05)。PIK3CA在BUC组中有74例(69.16%)表达显著增强,而在癌旁组中仅7例(25%)呈强阳性表达,两组间比较差异有统计学意义(P<0.05)。结合患者的临床病理特征进行分析,发现ARID1A的缺失表达与肿瘤的浸润深度、分级及Ki-67增殖指数有关(P<0.05),PIK3CA的阳性表达与肿瘤的浸润深度有关(P<0.05),与分级、Ki-67增殖指数无关(P>0.05)。相关性分析结果显示ARID1A与PIK3CA之间的表达无明确相关性(r=-0.062,P>0.05),复发与否与年龄、病变级别、浸润深度、PIK3CA蛋白阳性表达率呈正相关。结论:ARID1A及PIK3CA在BUC患者癌组织中的表达明显增强,且与病变级别、肿瘤浸润密切相关,但两种蛋白间并无相关性,二者可能通过不同的途径参与BUC的发生、进展。并且PIK3CA蛋白阳性表达可明显增加BUC的复发率,进一步为探究BUC提供了新的思路。 Objective:To investigate the expression and significance of ARID1 A and PIK3 CA in bladder urothelial carcinoma(BUC).Methods:Immunohistochemical methods were employed to evaluate protein level of ARID1 A and PIK3 CA in 107 cases of BUC and 28 cases of adjacent tissues.The BUC tissues were grouped by clinical and pathological features,and the difference and relations of ARID1 A and PIK3 CA in each group were analyzed.Results:The loss rate of ARID1 A was 42.06%in BUC,but only 7.14%in adjacent tissues.The positive rate of PIK3 CA in BUC(69.16%)was significantly higher than that in adjacent tissues(25%)(P<0.05).The clinical features of 107 cases of BUC were retrospectively analyzed,which showed that the expression of ARID1 A was significantly associated with histopathology grading,depth of invasion and Ki-67 index.The expression of PIK3 CA was significantly associated with depth of invasion,but not related to age,sexuality,recurrence or Ki-67 index(P>0.05).The results of correlation analysis showed that there was no clear correlation between ARID1 A and PIK3 CA(r=-0.062,P>0.05).The recurrence was positively correlated with age,histopathology grading,depth of invasion and PIK3 CA.Conclusion:ARID1 A and PIK3 CA play an important role in the development and progression of BUC through different pathways.The expression of PIK3 CA maybe increase the recurrence of BUC.It will provide a new idea for exploring the prevention and treatment of urothelial carcinoma of the bladder.
作者 王晨静 李超 咸娴 王胜 何雷 范多娇 WANG Chenjing;LI Chao;XIAN Xian;WANG Sheng;HE Lei;FAN Duojiao(Department of Pathology,Baoding Second Hospital,Baoding,Hebei,071051,China;Department of Pathology,Dingzhou People's Hospital;Department of Urology,Baoding Second Hospital;General Surgery and Oncology Department,Xushui District Peoples Hospital;Department of Science and Education,Baoding Second Hospital)
出处 《临床泌尿外科杂志》 CAS 2021年第6期425-430,共6页 Journal of Clinical Urology
基金 保定市科学技术研究与发展计划项目(No:2041ZF021)。
关键词 膀胱肿瘤 尿路上皮癌 AT丰富结合域1A 磷脂酰肌醇3-激酶催化亚基 免疫组织化学 bladder tumor urothelial carcinoma the AT-rich interactivedomain 1A phosphoinositide 3 kinase catalytic alpha polypeptide immunohistochemistry
  • 相关文献

参考文献5

二级参考文献31

  • 1Apaporn Menakongka,Tuangporn Suthiphongchai.Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion[J].World Journal of Gastroenterology,2010,16(6):713-722. 被引量:33
  • 2Maier VK, Chioda M, Becker PB. ATP-dependent chromatosome remodeling[J]. Biol Chem, 2008,389 (4) : 345 - 352.
  • 3Nie Z,Xue Y, Yang D, et al. A specificity and targeting subunit of a human SWI/SNF family-related chromatin- remodeling complex[J]. Mol Cell Biol, 2000,2(I (23) : 8879 - 8888.
  • 4Jones S, Wang TL, Shih Ie M, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell earcinoma[J]. Science, 2010,330 (600 l ) : 228 - 231.
  • 5Liang H, Cheung LW, Li J ,et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer[J]. Genome Res, 2012,22(11) :2120 - 2129.
  • 6Giulino-Roth L,Wang K, MacDonald TY, et al. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes [J]. Blood, 2012, 120 ( 26 ) : 5181 - 5184.
  • 7Fujimoto A, Totoki Y, Abe T, et al. Whole-genomesequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators[J]. Nat Genet, 2012,44(7) : 760 - 764.
  • 8Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy number changes identifies key genes and pathways in hepatocellular carcinoma[J]. Nat Genet, 2(112,44 (6) : 694 - 698.
  • 9Huang J,Deng Q, Wang Q, et al. Exome sequencing of hepatitis B virus-associated hepatocellular careinoma[J]. Nat Genet,2012,44(10) :1117- 1121.
  • 10Sausen M, Leary RJ, Jones S, et al. Integrated genomie analyses identify ARID1A and ARIDIB alterations in the :hildhood cancer neurohlastomaf-J. Nat Genet, 2013,45 (l):12-17.

共引文献16

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部